FoundationOne Liquid CDx
1 product
6 abstracts
Abstract
CUPCOMP: A multi-site UK trial in carcinoma of unknown primary: A comparison across tissue and liquid biomarkers.Org: Cancer Research UK National Biomarker Centre, Royal United Hospitals Bath NHS Foundation Trust, Torbay and South Devon NHS Foundation Trust, Velindre University NHS Trust, Clatterbridge Centre for Oncology NHS Foundation Trust,
Abstract
Actionability of comprehensive genomic profiling compared to the tissue-based and plasma-based assay in patients with metastatic breast cancer: A real-world study.Org: Department of Breast and Endocrine Surgical Oncology, Graduate School of Medicine, Tohoku University, Tohoku University Hospital, Miyagi Cancer Center, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Tohoku University Graduated School of Medcine,
Abstract
The effect of ctDNA tumor fraction (TF) on overall survival and concordance between tissue genomics and ctDNA in Lung-MAP.Org: Mount Sinai Health System, SWOG Statistics and Data Management Center, Seattle, WA, Fred Hutchinson Cancer Center/Division of Hematology and Oncology, Dana-Farber Cancer Institute, SWOG Statistical Center,
Abstract
Frequency of somatic mutations in solid tumor malignancies from inner city minorities: A single center study.Org: John H. Stroger, Jr. Hospital of Cook County, Chicago, IL,
Abstract
Comparison between liquid biopsy and tissue NGS in two cohorts of advanced NSCLC.Org: Department of Medical Oncology, Hospital Universitario 12 de Octubre. Universidad Complutense de Madrid, Madrid, Spain, Sapienza University of Rome, Medical Oncology Department, Policlinico Umberto I, Roma, Italy, Department of Medical Oncology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain, Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain, Pathology Department, Hospital Universitario 12 de Octubre. Universidad Complutense de Madrid. Research Institute Hospital 12 de Octubre (i+12). CIBERONC, Madrid, Spain,
Abstract
Utilization and barriers to genomic profiling in breast cancer treatment among oncologists.Org: Cardinal Health, Cardinal Health, LLC, Cardinal Health Specialty Solutions,